Clinical Trials · NCT01292252

Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion

Name: Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Teriparatide

Phase: Phase 4
Recruitment status: Completed
Sponsor: Shane Burch
Enrollment: 36
Start date: Aug 2011
Locations: 1 site, United States
Primary endpoint: Quality of Spine Fusion, Measured by the Number of Participants With Complete Spine Fusion at 1 Year

View Teriparatide compound reference